CVE-2023-40153
Cross-site Scripting in DEXMA DEXGate
- State
- Published
- Severity
- 5.4 Medium
- Published
- Oct 19, 2023
- Updated
- Sep 11, 2024
- Reserved
- Sep 12, 2023
Description
The affected product is vulnerable to a cross-site scripting vulnerability, which could allow an attacker to access the web application to introduce arbitrary Java Script by injecting an XSS payload into the 'hostname' parameter of the vulnerable software.
Scores
| CVSS | Score | Vector | Source |
|---|---|---|---|
| 3.1 | 5.4 Medium | CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N | icscert |
Weaknesses
- CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting')
Affected Products
| Product | Versions |
|---|---|
DexGateDEXMA |
|
References
Every record here comes from the CVE Program’s CVE List. © 1999–2026 The MITRE Corporation. CVE is a registered trademark of The MITRE Corporation. The records are reproduced under the CVE Program terms of use.